Actively Recruiting
Evaluating the Impact of Home-Based Sleep Apnea Diagnostic on Well-Being, Health Behavior, and AF Load in Patients with Atrial Fibrillation Using a Decentralized Platform
Led by Herlev and Gentofte Hospital · Updated on 2025-01-17
936
Participants Needed
1
Research Sites
133 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to find out if testing for sleep apnea (a condition where breathing stops and starts during sleep) at home can improve well-being in people with atrial fibrillation (an irregular heartbeat condition). About 936 participants will be involved. They will either be tested for sleep apnea and treated, if needed, or not tested at all. Researchers will compare the well-being and heart-related symptoms of participants who are tested for sleep apnea to those who are not. These will be tracked using a mobile app to monitor symptoms, physical activity, and heart rhythm. Main hypothesis: Participants with atrial fibrillation who are tested and possibly treated for sleep apnea will have improved quality of life scores (measured by the Atrial Fibrillation Effect on QualiTy-of-life (AFEQT) questionnaire) by at least 5 points after 18 weeks.
CONDITIONS
Official Title
Evaluating the Impact of Home-Based Sleep Apnea Diagnostic on Well-Being, Health Behavior, and AF Load in Patients with Atrial Fibrillation Using a Decentralized Platform
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Established diagnosis of paroxysmal or persistent atrial fibrillation
- Ownership of a compatible smartphone or willingness to use one provided by the investigators
- Understanding of possible sleep apnea treatment options including CPAP therapy
You will not qualify if you...
- Previous investigation for sleep-disordered breathing
- Advanced heart failure with left ventricular dysfunction and NYHA class III or IV
- Holding an occupational driver's license
- Pregnancy
- Current use of Doxazosin or Terazosin (alpha-adrenergic antagonists)
- Peripheral arterial disease causing daily intermittent claudication
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Herlev-Gentofte Hospital
Hellerup, Denmark, 2900
Actively Recruiting
Research Team
M
Morten Kjøbek Lamberts ML Associate Professor Lamberts
CONTACT
M
Mads Hashiba Jensen Hashiba, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here